Comorbid conditions, concomitant diuretic use up AKI risk after SGLT2i treatment in diabetics
Among patients with type 2 diabetes (T2D), the risk of acute kidney injury (AKI) after sodium-glucose co-transporter 2 inhibitor (SGLT2i) treatment is higher in men, older adults, and those with low body mass index (BMI), chronic heart failure, and concomitant diuretic use, a study has found.